Document -
Investment criteria of corporate venture capital in life science industry
The US continues to dominate; most venture capital goes to drug discovery platforms and the most successful companies in need of venture capital are those who most clearly fit in to investors' strategy. Despite a leading R&D position, Swedish life science companies must improve international relations to succeed in attracting investments. This emerged in a new report on corporate venture capital.
-
License:
Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
- File format: .pdf
Topics
- Economy, Finance
Categories
- venture capital
- funding
- investment strategies
- cvcs
- cvc
- corporate venture capital
- corporate venture capitalists
- big pharma
- life science industry
- life science
- parhat hebibul
- farhang modaresi
- ylva hultman erlandsson
- the city of stockholm
- stockholm business region
- stockholm
- fdi
- foreign direct investments
